Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models

被引:15
作者
Miller, Robert H. [1 ]
Fyffe-Maricich, Sharyl L. [1 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Neurosci, Ctr Translat Neurosci, Cleveland, OH 44106 USA
关键词
DRUGS MECHANISMS; ANIMAL-MODELS; GROWTH-FACTOR; IN-VITRO; MYELINATION; DEMYELINATION; CELLS; REMYELINATION; OLIGODENDROCYTES; DIFFERENTIATION;
D O I
10.1242/dmm.001958
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multiple sclerosis (MS) is considered an autoimmune-mediated demyelinating disease that targets the central nervous system (CNS). Despite considerable research efforts over multiple decades, our understanding of the basic biological processes that are targeted in the disease and the mechanisms of pathogenesis are poorly understood. Consequently, current therapies directed at controlling the progression of the disease are limited in their effectiveness. Historically, the primary focus of MS research has been to define the cellular and molecular basis of the immunological pathogenic mechanisms. Recently, however, it has become clear that long-term functional recovery in MS will require the development of strategies that facilitate myelin repair in lesion areas. The emerging evidence that the adult vertebrate CNS retains the capacity to regenerate neural cells that have been lost to disease or damage has provoked intensive research focused on defining the mechanisms of myelin repair. Unfortunately, the existing animal models of MS are poorly equipped to assess myelin repair, and new validated strategies to identify therapeutics targeted at promoting myelin repair are badly needed. This Commentary will review established murine models of MS, and discuss emerging technologies that promise to provide insights into the mechanisms of myelin repair.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 60 条
[1]   NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus [J].
Aguirre, AA ;
Chittajallu, R ;
Belachew, S ;
Gallo, V .
JOURNAL OF CELL BIOLOGY, 2004, 165 (04) :575-589
[2]   bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS [J].
Arnett, HA ;
Fancy, SPJ ;
Alberta, JA ;
Zhao, C ;
Plant, SR ;
Kaing, S ;
Raine, CS ;
Rowitch, DH ;
Franklin, RJM ;
Stiles, CD .
SCIENCE, 2004, 306 (5704) :2111-2115
[3]   Differential changes in axonal conduction following CNS demyelination in two mouse models [J].
Bando, Yoshio ;
Takakusaki, Kaoru ;
Ito, Shinji ;
Terayama, Ryuji ;
Kashiwayanagi, Makoto ;
Yoshida, Shigetaka .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (09) :1731-1742
[4]   Regulation of FGF receptors in the oligodendrocyte lineage [J].
Bansal, R ;
Kumar, M ;
Murray, K ;
Morrison, RS ;
Pfeiffer, SE .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1996, 7 (04) :263-275
[5]   The origin and application of experimental autoimmune encephalomyelitis [J].
Baxter, Alan G. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (11) :904-912
[6]   Prospects of Cell Therapy for Disorders of Myelin [J].
Ben-Hur, Tamir ;
Goldman, Steven A. .
YEAR IN NEUROLOGY 2008, 2008, 1142 :218-249
[7]   Monoclonal antibodies in MS Mechanisms of action [J].
Bielekova, Bibiana ;
Becker, Brenda L. .
NEUROLOGY, 2010, 74 (01) :S31-S40
[8]   Lysolecithin induces demyelination in vitro in a cerebellar slice culture system [J].
Birgbauer, E ;
Rao, TS ;
Webb, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 78 (02) :157-166
[9]  
Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193
[10]   Lipid autoreactivity in multiple sclerosis [J].
Blewett, M. M. .
MEDICAL HYPOTHESES, 2010, 74 (03) :433-442